Pradaxa (dabigatran etexilate mesylate) is an anticoagulant. It treats patients with atrial fibrillation (AF) by keeping blood from clotting. The FDA is investigating reports in patients treated with Pradaxa® with uncontrollable bleeding. In December 2011, the FDA made a Safety Announcement, “At this time, FDA continues to believe that Pradaxa® provides an important health benefit when used as directed.” However, there are still public health officials concerned about the rise in Pradaxa®-related internal bleeding and deaths.

Life-Threatening Internal Bleeding Events

spilled pills

There is no reversal agent for it. There are no drugs today which can stop internal bleeding. This causes hemorrhaging until coma, organ damage, and/or death occur.

Death from Pradaxa® Bleeding

In fact, are several reports of deaths due to Pradaxa® treatment. For example, an elderly Utah man who had a minor fall in February 2012. Doctors found his brain bleeding uncontrollably. The man’s treatment of Pradaxa® made efforts to stop the bleeding ineffective, resulting in his death.

Other Pradaxa® Side Effects

  • vomiting blood or vomit that looks like coffee grounds
  • unusual bleeding from the gums
  • coughing up blood or blood clots
  • menstrual or vaginal bleeding that is heavier than normal
  • heart attack

.

Don’t Delay! Call Clay!

We represent people harmed by medications and can help you and your family pursue damages. Contact The Law Offices of L. Clayton Burgess Today!